Sonoma Pharmaceuticals, Inc. ( SNOA) - Stock Earnings
SNOA Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 16, 2026, midnight | — / — | — | — / — | — |
SNOA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -819000 USD | 4.3 million USD |
| 2026Q1 | -581000 USD | 5.6 million USD |
| 2026Q2 | -330000 USD | 6.4 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
SNOA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | -4.8 million USD | 12.7 million USD |
| 2025 | -3.5 million USD | 14.3 million USD |
| 2026 | -3.2 million USD | 19.5 million USD |
| 2026 Est. | — | — |
SNOA
Price: $1.14
Earnings Per Share: -1.22 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 313242
Ebitda: -12.7 millionMarket Capitalization: 5.8 million